Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cue Biopharma (CUE) Shares Outstanding (2017 - 2025)

Cue Biopharma's Shares Outstanding history spans 9 years, with the latest figure at $77.8 million for Q3 2025.

  • For Q3 2025, Shares Outstanding rose 29.19% year-over-year to $77.8 million; the TTM value through Sep 2025 reached $77.8 million, up 29.19%, while the annual FY2024 figure was $61.8 million, 30.93% up from the prior year.
  • Shares Outstanding for Q3 2025 was $77.8 million at Cue Biopharma, up from $76.4 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $77.8 million in Q3 2025 and bottomed at $30.5 million in Q1 2021.
  • The 5-year median for Shares Outstanding is $43.7 million (2023), against an average of $46.8 million.
  • The largest annual shift saw Shares Outstanding rose 4.56% in 2021 before it soared 57.16% in 2025.
  • A 5-year view of Shares Outstanding shows it stood at $32.2 million in 2021, then skyrocketed by 33.66% to $43.0 million in 2022, then increased by 9.69% to $47.2 million in 2023, then soared by 30.93% to $61.8 million in 2024, then grew by 25.82% to $77.8 million in 2025.
  • Per Business Quant, the three most recent readings for CUE's Shares Outstanding are $77.8 million (Q3 2025), $76.4 million (Q2 2025), and $61.8 million (Q1 2025).